In clinical trials, Ipamorelin was well tolerated, with no significant effects on prolactin or cortisol secretion compared to other GHRPs. van den Berghe et al., The Journal of Clinical Endocrinology & Metabolism Rare or Potential Concerns Injection site irritation (especially with poor reconstitution technique) Overstimulation of GH axis with excessive dosing or stacking GH-related side effects at high doses (e.g., mild carpal tunnel, joint tightness) These are more likely in unsupervised high-dose or long-term protocols , especially when paired with additional GH-enhancing compounds
Klinics care team will go beyond expectations to confirm your benefits, submit prior authorization documents, and negotiate with major insurers like UnitedHealthcare, Cigna, Blue Cross Blue Shield, Aetna, Medicare Part D, and Medicaid
Your provider can recommend the timing that works best for your schedule and your body
A: It is the first triple agonist (GLP-1 + GIP + Glucagon) studied in Phase 3 trials